_archives

23andMe Has Abandoned The Genetic Testing Tech Its Competition Is Banking On

Resources

Healthcare Customer Journey Mapping | Macadamian

From product to customer experience: The new way to launch in pharma

Digital Customer Journey Mapping: Improving the Customer Experience

Self-Service Analytics, Data Science & Process Automation | Alteryx

Genome Sequencing Industry 2020

Population Health Solutions | Helix

Renown IHI case study

OneTrust | Privacy Management Software

Helix - COVID Testing and Research

Data Upload Consent

Platform Consent

Helix - Population Genomics

Supporting Global COVID-19 Efforts

Illumina | Sequencing and array-based solutions for genetic research

SGS | When You Need To Be Sure

Scientific Equipment Leasing Company | Excedr

Blog - Europe PMC

299521348 23and me a new two sided data banking market model

325581955 23and me future of genomic services business

23andme: Future of Personal Genomics Services Business?

Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing

Lab Products & Solutions for SARS-CoV-2 Research | Thermo Fisher Scientific - US

Epidemiological Research Solutions for SARS-CoV-2 | Thermo Fisher Scientific - US

SARS-CoV-2 Research Solutions | Thermo Fisher Scientific - US

23andMe: Current personal genomics market leader turned market loser? - Digital Innovation and Transformation

Beaumont researchers develop COVID-19 test that can detect virus in saliva, blood or urine in 45 minutes

Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective

Genetic Testing and Commercialized Biobanks: Exploring Ethical Issues